Molecular Pharmaceutics
[ASAP] Regional Transcriptomics and Proteomics of Pharmacokinetics-Related Genes in Human Intestine
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01002
Molecular Pharmaceutics
[ASAP] Characterization of Bile Acid Sulfate Conjugates as Substrates of Human Organic Anion Transporting Polypeptides
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00040
Molecular Pharmaceutics
[ASAP] Voices in Molecular Pharmaceutics: Meet Dr. Wei Zhang, a Pharmaceutical Scientist Developing Drug Products for Patients
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00337
Molecular Pharmaceutics
[ASAP] Usefulness of the Beagle Model in the Evaluation of Paracetamol and Ibuprofen Exposure after Oral Administration to Pediatric Populations: An Exploratory Study
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00926
Molecular Pharmaceutics
[ASAP] Recent Advances in Targeting the Urokinase Plasminogen Activator with Nanotherapeutics
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00055
Molecular Pharmaceutics
[ASAP] Effect of Albumin Corona Conformation on <italic toggle=”yes”>In Vitro</italic> and <italic toggle=”yes”>In Vivo</italic> Profiles of Intravenously Administered Nanoparticles
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00021
Molecular Pharmaceutics
[ASAP] Improved Melatonin Delivery by a Size-Controlled Polydopamine Nanoformulation Attenuates Preclinical Diabetic Retinopathy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01039
Molecular Pharmaceutics
[ASAP] Coumarin-Based Fluorescent Inhibitors for Photocontrollable Bioactivation
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00279
Molecular Pharmaceutics
[ASAP] Effects of Local Anesthetics on Liposomal Membranes Determined by Their Inhibitory Activity of Lipid Peroxidation
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01053
Molecular Pharmaceutics
[ASAP] Prediction of Compound Plasma Concentration–Time Profiles in Mice Using Random Forest
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00071